MedPath

Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy

Phase 2
Conditions
Epilepsy
Epilepsia
Epileptic Seizures
Seizure Disorder
Interventions
Behavioral: Physical activity
Registration Number
NCT01450423
Lead Sponsor
Lars Bo Andersen
Brief Summary

Epilepsy is a chronic neurologic disorder characterized by seizures. Beside seizures people suffering from epilepsy experience several challenges related to education, work and everyday life such as learning-, problem-solving-, memory-, concentration-, attention difficulties and fatigue.

It is generally approved that physical activity (PA) has a positive effect on physical as well as mental factors. However, people with epilepsy are found to be less active and PA is rarely offered or recommended as supplement to anti-epileptic medical treatment. Few studies have investigated the effect of PA in subjects with epilepsy and additional studies of high methodical quality are needed to enable evidence-based information and counselling.

This study is carried through as a randomized controlled trial which investigates the effect of participation in a 10-week cardio exercise program in people with Juvenile Myoclonic Epilepsy aged 15-50.

The study hypothesis is that participation in a 10-week cardio exercise program will induce a positive change in cognitive function (concentration and attention) and possibly in brain-derived neurotrophic factor (BDNF). In addition it is expected that the intensity and duration of the 10-week cardio exercise program is sufficient to cause changes in physiological parameters related to a reduced risk of lifestyle diseases.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age: 15-50
  • Resident: Fyen, Denmark
  • Epileptic syndrome: Juvenile Myoclonic Epilepsy
Exclusion Criteria
  • Physical handicaps which complicate participation in physical activity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physical activityPhysical activity-
Primary Outcome Measures
NameTimeMethod
Cognitive function (concentration and attention)Before and after a 10-week intervention period

To assess cognitive function the following tests are used: Connor's Continuous Performance Test (CPT II), Trail Making Test part A and part B, Digit Symbol Modalities Test

physical fitnessBefore and after a 10-week intervention period

To assess physical fitness the following test are used: Wattmax test

Secondary Outcome Measures
NameTimeMethod
Brain-derived neurotrophic factor (BDNF)Before and after a 10-week intervention period (chronic and acute)

The chronic level of serum brain-derived neurotrophic factor (BDNF) is assessed in fasting blood samples. The acute level of serum BDNF is assessed in blood samples drawn immediately after completed wattmax test.

Bone mineral densityBefore and after a 10-week intervention period

To assess bone mineral density the following test is used: DEXA-scanning

Thyroidea Stimulating Hormone (TSH)Before and after a 10-week intervention period

The level of serum Thyroidea Stimulating Hormone (TSH) is assessed in fasting blood samples.

InsulinBefore and after a 10-week intervention period

The level of insulin is assessed in fasting blood samples.

GlucoseBefore and after a 10-week intervention period

The level of glucose is assessed in fasting blood samples

LipidsBefore and after a 10-week intervention period

The levels of lipids are assessed in fasting blood samples.

C-reactive-proteinBefore and after a 10-week intervention period

The level of c-reactive-protein is assessed in fasting blood samples.

Seizure frequencyBefore and after a 10-week intervention period

Seizure frequency is assessed by a neurologist using a standard seizure calender.

Blood pressureBefore and after a 10-week intervention period

Trial Locations

Locations (2)

Center of Research in Childhood Health, University of Southern Denmark

🇩🇰

Odense, Region of Southern Denmark, Denmark

Epilepsy clinic, Odense University Hospital

🇩🇰

Odense, Region of Southern Denmark, Denmark

© Copyright 2025. All Rights Reserved by MedPath